查看所有供应商和价格请点击：
| 中文名 | 硫酸氧钒(Ⅳ)水合物 |
|---|---|
| 英文名 | Vanadyl(IV) sulfate hydrate |
| 中文别名 |
硫酸氧化钒
硫酸氧钒 |
| 英文别名 |
vanadyl sulfate hydrate
vanadium,oxo[sulfato(2-)-ko]-,hydrate (1:5) vanadium(iv) oxide sulfate hydrate MFCD00149933 vanadium (iv) oxide sulfate hydrate EINECS 248-652-7 vanadium(iv)-oxide sulfate 5-hydrate |
| 沸点 | 330ºC at 760 mmHg |
|---|---|
| 熔点 | 105 °C(lit.) |
| 分子式 | H2O10SV |
| 分子量 | 245.01600 |
| 精确质量 | 244.88100 |
| PSA | 114.94000 |
| 蒸汽压 | 3.35E-05mmHg at 25°C |
| 储存条件 | 密闭于阴凉干燥环境中 |
| 稳定性 | 遵照规定使用和储存则不会分解。 |
| 分子结构 | 1、摩尔折射率：无可用 2、 摩尔体积（cm3/mol）：无可用 3、 等张比容（90.2K）：无可用 4、 表面张力（dyne/cm）：无可用 5、 极化率：无可用 |
| 计算化学 | 1.疏水参数计算参考值（XlogP）:无 2.氢键供体数量:5 3.氢键受体数量:10 4.可旋转化学键数量:0 5.互变异构体数量:无 6.拓扑分子极性表面积111 7.重原子数量:12 8.表面电荷:0 9.复杂度:64.2 10.同位素原子数量:0 11.确定原子立构中心数量:0 12.不确定原子立构中心数量:0 13.确定化学键立构中心数量:0 14.不确定化学键立构中心数量:0 15.共价键单元数量:7 |
| 更多 | 1. 性状：无可用 2. 密度（g/mL,25/4℃）：无可用 3. 相对蒸汽密度（g/mL,空气=1）：无可用 4. 熔点（ºC）：105 5. 沸点（ºC,常压）：无可用 6. 沸点（ºC,5.2kPa）：无可用 7. 折射率：无可用 8. 闪点（ºC）：无可用 9. 比旋光度（º）：无可用 10. 自燃点或引燃温度（ºC）：无可用 11. 蒸气压（kPa,25ºC）：无可用 12. 饱和蒸气压（kPa,60ºC）：无可用 13. 燃烧热（KJ/mol）：无可用 14. 临界温度（ºC）：无可用 15. 临界压力（KPa）：无可用 16. 油水（辛醇/水）分配系数的对数值：无可用 17. 爆炸上限（%,V/V）：无可用 18. 爆炸下限（%,V/V）：无可用 19. 溶解性：无可用 |
Synonym:Oxysulfato vanadium (IV) hydrate; Vanadium oxysulfate; Oxo[sulfato(2-)-O]-Vanadium; Vanadyl (IV) sulfate; Oxysulfato vanadium (IV); Vanadium (IV) sulfate oxide; Vanadyl(IV)-sulfate hydrat Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
Risk Phrases: 22 36/37/38 Section 3 - HAZARDS IDENTIFICATION EMERGENCY OVERVIEW
Harmful if swallowed. Irritating to eyes, respiratory system and skin. Potential Health Effects Eye: Causes eye irritation. May cause chemical conjunctivitis. Skin: Causes skin irritation. Ingestion: May cause gastrointestinal irritation with nausea, vomiting and diarrhea. Vanadium compounds can cause polycythemia (an increase in the total red cell mass of the blood), followed by red blood cell destruction, anemia, loss of appetite, pallor, and emaciation. May cause greenish-black tongue discoloration due to deposition of vanadium salts. Inhalation: Causes respiratory tract irritation. Can produce delayed pulmonary edema. Chronic: Effects may be delayed. May produce scattered allergy-like eczematous skin lesions symptomatic of vanadium toxicity. Section 4 - FIRST AID MEASURES Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid. Skin: Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse. Ingestion: Do not induce vomiting. If victim is conscious and alert, give 2-4 cupfuls of milk or water. Never give anything by mouth to an unconscious person. Get medical aid. Inhalation: Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid. Notes to Physician: Treat symptomatically and supportively. Section 5 - FIRE FIGHTING MEASURES General Information: As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. This material in sufficient quantity and reduced particle size is capable of creating a dust explosion. Extinguishing Media: Use agent most appropriate to extinguish fire. Use water spray, dry chemical, carbon dioxide, or appropriate foam. Section 6 - ACCIDENTAL RELEASE MEASURES General Information: Use proper personal protective equipment as indicated in Section 8. Spills/Leaks: Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions. Provide ventilation. Section 7 - HANDLING and STORAGE Handling: Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation. Use with adequate ventilation. Wash clothing before reuse. Storage: Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances. Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION Engineering Controls: Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low. Exposure Limits CAS# 12439-96-2: CAS# 27774-13-6: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166. Skin: Wear appropriate protective gloves to prevent skin exposure. Clothing: Wear appropriate protective clothing to prevent skin exposure. Respirators: A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use. Section 9 - PHYSICAL AND CHEMICAL PROPERTIES Physical State: Crystals Color: blue Odor: None reported. pH: Not available. Vapor Pressure: Not available. Viscosity: Not available. Boiling Point: Not available. Freezing/Melting Point: Not available. Autoignition Temperature: Not applicable. Flash Point: Not applicable. Explosion Limits, lower: Not available. Explosion Limits, upper: Not available. Decomposition Temperature: Solubility in water: Soluble. Specific Gravity/Density: Molecular Formula: O5SV.xH2O Molecular Weight: 163.00 Section 10 - STABILITY AND REACTIVITY Chemical Stability: Stable under normal temperatures and pressures. Conditions to Avoid: Incompatible materials, dust generation, excess heat. Incompatibilities with Other Materials: Chlorine, lithium, strong acids, strong oxidizing agents. Hazardous Decomposition Products: Oxides of sulfur, irritating and toxic fumes and gases. Hazardous Polymerization: Has not been reported. Section 11 - TOXICOLOGICAL INFORMATION RTECS#: CAS# 12439-96-2: YW1840000 CAS# 27774-13-6: YW1925000 LD50/LC50: CAS# 12439-96-2: Oral, mouse: LD50 = 467 mg/kg; Oral, mouse: LD50 = 467 mg/kg; Oral, rat: LD50 = 448 mg/kg; Oral, rat: LD50 = 448 mg/kg. CAS# 27774-13-6: Skin, rabbit: LD50 = 4450 mg/kg. Carcinogenicity: Vanadyl(IV)-sulfate hydrate - Not listed by ACGIH, IARC, or NTP. Vanadyl sulfate - Not listed by ACGIH, IARC, or NTP. Other: See actual entry in RTECS for complete information. Section 12 - ECOLOGICAL INFORMATION Section 13 - DISPOSAL CONSIDERATIONS Dispose of in a manner consistent with federal, state, and local regulations. Section 14 - TRANSPORT INFORMATION IATA Shipping Name: VANADYL SULPHATE Hazard Class: 6.1 UN Number: 2931 Packing Group: II IMO Shipping Name: VANADYL SULPHATE Hazard Class: 6.1 UN Number: 2931 Packing Group: II RID/ADR Shipping Name: VANADYL SULPHATE Hazard Class: 6.1 UN Number: 2931 Packing group: II USA RQ: CAS# 27774-13-6: 1000 lb final RQ; 454 kg final RQ Section 15 - REGULATORY INFORMATION European/International Regulations European Labeling in Accordance with EC Directives Hazard Symbols: XN Risk Phrases: R 22 Harmful if swallowed. R 36/37/38 Irritating to eyes, respiratory system and skin. Safety Phrases: S 24/25 Avoid contact with skin and eyes. WGK (Water Danger/Protection) CAS# 12439-96-2: No information available. CAS# 27774-13-6: No information available. Canada CAS# 27774-13-6 is listed on Canada's DSL List. CAS# 12439-96-2 is not listed on Canada's Ingredient Disclosure List. CAS# 27774-13-6 is listed on Canada's Ingredient Disclosure List. US FEDERAL TSCA CAS# 12439-96-2 is not listed on the TSCA inventory. It is for research and development use only. CAS# 27774-13-6 is listed on the TSCA inventory. SECTION 16 - ADDITIONAL INFORMATION N/A |
|
生态学数据: 该物质对环境可能有危害，对水体应给予特别注意。
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|